Radiotherapy & Oncology
Volume 88, Issue 2 , Pages 173-176 , August 2008

A phase III study of accelerated versus conventional hypofractionated whole brain irradiation in patients of good performance status with brain metastases not suitable for surgical excision

  • Phillip Davey

      Affiliations

    • Department of Radiation Oncology, Odette Cancer Centre and University of Toronto, Toronto, ON, Canada
    • Corresponding Author InformationCorresponding author. Phillip Davey, Department of Radiation Oncology, Odette Cancer Centre and University of Toronto, Odette Cancer Centre, 2075 Bayview Avenue, T-Wing, Toronto, ON, Canada.
    • ,
  • David Hoegler

      Affiliations

    • Department of Radiation Oncology, Cancer Centre of the Southern Interior and University of British Columbia, Kelowna, BC, Canada
    • ,
  • Marguerite Ennis

      Affiliations

    • Applied Statistician, Markham, ON, Canada
    • ,
  • Jennifer Smith

      Affiliations

    • Department of Radiation Oncology, Odette Cancer Centre and University of Toronto, Toronto, ON, Canada

Received 17 August 2007 ,Revised 6 May 2008 ,Accepted 17 May 2008.

References 

  1. Khanduri S, Gerrard G, Barton R, Mulvenna P, Lee SM. Clinical trials assessing the optimal management of brain metastases – the state of play. Clin Oncol. 2006;18:744–746
  2. Borgelt B, Gelber R, Larson M, Hendrickson F, Griffin T, Roth R. Ultra-rapid high dose irradiation schedules for the palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys. 1981;7:1633–1638
  3. Kurtz JM, Gelber R, Brady LW, Carella RJ, Cooper JS. The palliation of brain metastases in a favourable patient population: a randomized clinical trial by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys. 1981;7:891–895
  4. Haie-Meder C, Pellae-Cosset B, Laplanche A, et al. Results of a randomized clinical trial comparing two radiation schedules in the palliative treatment of brain metastases. Radiother Oncol. 1993;26:111–116
  5. Priestman TJ, Dunn J, Brada M, Rampling R, Baker PG. Final results of the Royal College of Radiologists’ Trial comparing two different radiotherapy schedules in the treatment of cerebral metastases. Clin Oncol. 1996;308–315
  6. Hoskin PJ, Brada M. Radiotherapy for brain metastases. Clin Oncol. 2001;13:91–94
  7. Gaspar L, Scott C, Rotman M, et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys. 1997;37:745–751
  8. Vecht CJ, Haaxma-Reiche H, Noordijk EM, et al. Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery?. Ann Neurol. 1993;33:583–590
  9. Thomas R, Guerrero D, Hines F, Ashley S, Brada M. Modifying the Barthel Performance Index Score for use in patients with brain tumours. Eur J Cancer Care (Engl). 1995;4:63–68
  10. Farnell GF, Buckner JC, Cascino TL, O’Connell MJ, Schomberg PJ, Suman V. Brain metastases from colorectal carcinoma. Am Cancer Soc. 1996;78:711–716
  11. Hammoud MA, McCutcheon IE, Elsouki R, Schoppa D, Patt YZ. Colorectal carcinoma and brain metastasis: distribution, treatment, and survival. Ann Surg Oncol. 1996;3:453–463
  12. Bezjak A, Adam J, Panzarella T, et al. Radiotherapy for brain metastases: defining palliative response. Radiother Oncol. 2001;61:71–76
  13. Bezjak A, Adam J, Barton R, et al. Symptom response after palliative radiotherapy for patients with brain metastases. Eur J Cancer. 2002;38:487–496
  14. Chow E, Davis L, Holden L, Tsao M, Danjoux C. Prospective assessment of patient-rated symptoms following whole brain radiotherapy for brain metastases. J Pain Symptom Manage. 2005;30:18–23

PII: S0167-8140(08)00275-2

doi: 10.1016/j.radonc.2008.05.020

Radiotherapy & Oncology
Volume 88, Issue 2 , Pages 173-176 , August 2008

Article Tools

* Image Usage & Resolution